Patents by Inventor Enno Schweinberger

Enno Schweinberger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7847075
    Abstract: Within oligonucleotides, 2-azapurine and especially 2-azaadenine bases form specifically base pairs with guanine. This base pair is of analogous stability as an adenine-thymine but less stable than a guanine-cytosine base pair. Therefore, the incorporation of 2-azaadenine residues into oligonucleotides instead of cytosine leads specifically to hybridization complexes with nucleic acids with homogenous stability. This is useful for the adaptation of the stabilities of different oligonucleotide sequences in all kinds of hybridization techniques, for example in oligomer chip technology.
    Type: Grant
    Filed: August 13, 2009
    Date of Patent: December 7, 2010
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Frank Seela, Helmut Rosemeyer, Enno Schweinberger, Dieter Heindl, Frank Bergmann
  • Publication number: 20090306360
    Abstract: Within oligonucleotides, 2-azapurine and especially 2-azaadenine bases form specifically base pairs with guanine. This base pair is of analogous stability as an adenine-thymine but less stable than a guanine-cytosine base pair. Therefore, the incorporation of 2-azaadenine residues into oligonucleotides instead of cytosine leads specifically to hybridization complexes with nucleic acids with homogenous stability. This is useful for the adaptation of the stabilities of different oligonucleotide sequences in all kinds of hybridization techniques, for example in oligomer chip technology.
    Type: Application
    Filed: August 13, 2009
    Publication date: December 10, 2009
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Frank Seela, Helmut Rosemeyer, Enno Schweinberger, Dieter Heindl, Frank Bergmann
  • Patent number: 7612187
    Abstract: Within oligonucleotides 2-azapurine and especially 2-azaadenine bases form specifically base pairs with guanine. This base pair is of analogous stability as an adenine-thymine but less stable than a guanine-cytosine base pair. Therefore, the incorporation of 2-azaadenine residues into oligonucleotides instead of cytosine leads specifically to hybridization complexes with nucleic acids with homogenous stability. This is useful for the adaptation of the stabilities of different oligonucleotide sequences in all kinds of hybridization techniques, for example in oligomer chip technology.
    Type: Grant
    Filed: May 25, 2006
    Date of Patent: November 3, 2009
    Assignee: Roche Diagnostics, GmbH
    Inventors: Frank Seela, Helmut Rosemeyer, Enno Schweinberger, Dieter Heindl, Frank Bergmann
  • Publication number: 20090208583
    Abstract: Composition in the form of a tablet, comprising candesartan cilexetil and optionally further active agents and usual adjuncts, wherein the surface of at least the active agent candesartan cilexetil in this composition is provided with a coating, made from a compound or a mixture of compounds selected from tri-(C1-C6)alkyl citrate, di-(C1-C6)alkyl phthalate, di-(C1-C6)alkyl sebacate and polydimethysiloxanes and methods for production thereof.
    Type: Application
    Filed: June 14, 2007
    Publication date: August 20, 2009
    Applicant: Siegfried Generics International AG
    Inventors: Tillmann Rohrich, Waltraud Bueb, Enno Schweinberger
  • Patent number: 7169553
    Abstract: Within oligonucleotides 2-azapurine and especially 2-azaadenine bases form specifically base pairs with guanine. This base pair is of analogous stability as an adenine-thymine but less stable than a guanine-cytosine base pair. Therefore, the incorporation of 2-azaadenine residues into oligonucleotides instead of cytosine leads specifically to hybridization complexes with nucleic acids with homogenous stability. This is useful for the adaptation of the stabilities of different oligonucleotide sequences in all kinds of hybridization techniques, for example in oligomer chip technology.
    Type: Grant
    Filed: August 28, 2000
    Date of Patent: January 30, 2007
    Assignee: Roche Diagnostics, GmbH
    Inventors: Frank Seela, Helmut Rosenmeyer, Enno Schweinberger, Dieter Heindl, Frank Bergmann
  • Publication number: 20070015725
    Abstract: Within oligonucleotides 2-azapurine and especially 2-azaadenine bases form specifically base pairs with guanine. This base pair is of analogous stability as an adenine-thymine but less stable than a guanine-cytosine base pair. Therefore, the incorporation of 2-azaadenine residues into oligonucleotides instead of cytosine leads specifically to hybridization complexes with nucleic acids with homogenous stability. This is useful for the adaptation of the stabilities of different oligonucleotide sequences in all kinds of hybridization techniques, for example in oligomer chip technology.
    Type: Application
    Filed: May 25, 2006
    Publication date: January 18, 2007
    Applicant: Roche Diagnostics, GMBH
    Inventors: Frank Seela, Helmut Rosemeyer, Enno Schweinberger, Dieter Heindl, Frank Bergmann